Cell-free DNA in newly diagnosed patients with glioblastoma – a clinical prospective feasibility study

Background: Glioblastoma (GB) is an incurable brain cancer with limited treatment options. The aim was to test the feasibility of using cell-free DNA (cfDNA) to support evaluation of treatment response, pseudo-progression and whether progression could be found before clinical and/or radiologic progr...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncotarget
Главные авторы: Nørøxe, Dorte Schou, Østrup, Olga, Yde, Christina Westmose, Ahlborn, Lise Barlebo, Nielsen, Finn Cilius, Michaelsen, Signe Regner, Larsen, Vibeke Andrée, Skjøth-Rasmussen, Jane, Brennum, Jannick, Hamerlik, Petra, Poulsen, Hans Skovgaard, Lassen, Ulrik
Формат: Artigo
Язык:Inglês
Опубликовано: Impact Journals LLC 2019
Предметы:
Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6633897/
https://ncbi.nlm.nih.gov/pubmed/31320993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27030
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы